Intent to Sole Source - Medrad Stellant Flex OCS Injection System
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Bethesda, MD
- Industry: Surgical and Medical Instrument Manufacturing
Contract Details
- Notice ID
- NOI-OLAO-CC-26-009364
- Opportunity Type
- Special Notice
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH
- Posted Date
- Wednesday, September 16, 2026
- Response Deadline
- Saturday, September 26, 2026
- PSC Code
- 6640
- Set-Aside
- No Set Aside
- Place of Performance
- Bethesda, MD, 20892
- Status
- Active
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bayer Healthcare LLC. Acquistion Description: The Center for Interventional Oncology in the Clinical Center/Radiology and Imaging Sciences and the National Cancer Institutes Center for Cancer Research conduct highly advanced research in dual layer spectral computed tomography (CT) imaging, developing new clinical applications. These ongoing studies require the injection of x-ray contrast under precisely controlled conditions, including timing, volume, and rate of injection. The specialized contrast injection system is integrated into the existing CT system and communicates with the
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for surgical and medical instrument manufacturing with a set-aside for No Set Aside businesses in Bethesda, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts